A multitude of new treatment options for individuals living with type 1 diabetes mellitus (T1DM) are currently in development or have recently been approved. Recognizing the limitations of currently available insulin preparations, the focus of research endeavors and newly marketed products hinges on the...
Type-1 diabetes—the sort caused by failure of the insulin-producing beta cells of the pancreas—is famous in medical history for the development just over a century ago of insulin treatment. That was the first time an isolated hormone had been used as a medicine. The disease may soon clock...
covering a diverse range of topics including artificial intelligence-driven decision support systems, glucose sensors, closed-loop systems, artificial pancreas technology, screening, intervention and prevention of type 1 diabetes, preventive devices for diabetes, new medications, innovative insulin delivery sy...
Following encouraging results from pre-clinical research and a recent clinical trial on stem cell-based treatments for patients with type 1 diabetes, researchers are now working on maximizing the function and potential of stem cell-based treatments for f
Significance and practice of drug treatments for type 1 diabetes mellitus This review article summarizes the recent research trends for the treatment of type 1 diabetes (T1D) based on islets transplantation and drug delivery syst... 山口 いずみ,西村 理明,阪本 要一 - 《Japanese Journal of Clin...
Justin Gregory, MD, left, Jordan Smith, RN, and colleagues are studying a possible new treatment that could lead to better health and longer lives for patients with Type 1 diabetes. Credit: John Russell Researchers at Vanderbilt University Medical Center led by an assistant professor of Pediatrics...
1.A method for identifying a subject at risk for a disorder associated with diabetes, said disorder being characterized by abnormally high levels of glycated CD59 protein, comprising;obtaining a level of the amount of K41-glycated CD59 from a sample obtained from the subject, andcomparing the le...
Background Economic models are considered to be important, as they help evaluate the long-term impact of diabetes treatment. To date, it appears that no ar... CV Asche,SE Hippler,DT Eurich - 《Pharmacoeconomics》 被引量: 38发表: 2014年 Do we need new treatments for type 2 diabetes? Diag...
New trials are underway at UCSF for type 1 diabetes patients who are within two years of diagnosis. Each is aimed at reining in the autoimmune attack on beta cells. A related trial that is just getting started is a prevention study. The researchers aim to stop beta cell destruction in high...
Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1 Current therapies for type 2 diabetes are frequently associated with inadequate control of postprandial hyperglycemia, weight gain, and, in the case of ora... MC Riddle,DJ Drucker - 《Diabetes Care》 被引量: 219发表:...